ArticleAmerican journal of hematology2026

Post CAR-T Measurable Residual Disease Monitoring in Mantle Cell Lymphoma Enables Early Detection of Disease Relapse.

Snegha Ananth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.